Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Diagnostic and prognostic significance of serum microRNAs in colorectal cancer.

Menéndez P, Villarejo P, Padilla D, Menéndez JM, Montes JA.

J Surg Oncol. 2013 Feb;107(2):217-20. doi: 10.1002/jso.23245. Epub 2012 Aug 17. Review.

PMID:
22903548
2.

Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.

Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, Ling S, Jiang L, Tian Y, Lin TY.

J Gastroenterol Hepatol. 2010 Oct;25(10):1674-80. doi: 10.1111/j.1440-1746.2010.06417.x.

PMID:
20880178
3.

Implications of the histological determination of microRNAs in the screening, diagnosis and prognosis of colorectal cancer.

Menéndez P, Villarejo P, Padilla D, Menéndez JM, Rodríguez-Montes JA.

J Surg Oncol. 2013 Jul;108(1):70-3. doi: 10.1002/jso.23344. Epub 2013 Apr 22. Review.

PMID:
23609475
4.

MicroRNA and colorectal cancer.

Corté H, Manceau G, Blons H, Laurent-Puig P.

Dig Liver Dis. 2012 Mar;44(3):195-200. doi: 10.1016/j.dld.2011.10.010. Epub 2011 Nov 21. Review.

PMID:
22105087
5.

MicroRNA dysregulation in colorectal cancer: a clinical perspective.

Dong Y, Wu WK, Wu CW, Sung JJ, Yu J, Ng SS.

Br J Cancer. 2011 Mar 15;104(6):893-8. doi: 10.1038/bjc.2011.57. Epub 2011 Mar 1. Review.

6.

Re: Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

Masuda S, Izpisua Belmonte JC.

J Natl Cancer Inst. 2014 Mar;106(3):djt457. doi: 10.1093/jnci/djt457. Epub 2014 Mar 1. No abstract available.

7.

Circulating miR-34a levels are reduced in colorectal cancer.

Nugent M, Miller N, Kerin MJ.

J Surg Oncol. 2012 Dec;106(8):947-52. doi: 10.1002/jso.23174. Epub 2012 May 30.

PMID:
22648208
8.

The role of microRNAs in colorectal cancer.

Liu M, Chen H.

J Genet Genomics. 2010 Jun;37(6):347-58. doi: 10.1016/S1673-8527(09)60053-9. Epub 2010 Jul 1. Review.

PMID:
20621017
9.

MicroRNAs as biomarkers in colorectal cancer.

Schee K, Fodstad Ø, Flatmark K.

Am J Pathol. 2010 Oct;177(4):1592-9. doi: 10.2353/ajpath.2010.100024. Epub 2010 Sep 9. Review.

10.

Plasma microRNAs: a potential biomarker for colorectal cancer?

Schetter AJ, Harris CC.

Gut. 2009 Oct;58(10):1318-9. doi: 10.1136/gut.2009.176875. No abstract available.

PMID:
19749133
11.

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.

Slaby O, Svoboda M, Michalek J, Vyzula R.

Mol Cancer. 2009 Nov 14;8:102. doi: 10.1186/1476-4598-8-102. Review.

12.

Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.

Wang LG, Gu J.

Cancer Epidemiol. 2012 Feb;36(1):e61-7. doi: 10.1016/j.canep.2011.05.002. Epub 2011 Oct 21.

PMID:
22018950
13.

miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.

Ma Y, Zhang P, Wang F, Zhang H, Yang J, Peng J, Liu W, Qin H.

Gut. 2012 Oct;61(10):1447-53. doi: 10.1136/gutjnl-2011-301122. Epub 2011 Nov 3.

PMID:
22052060
14.

Serum microRNAs as powerful cancer biomarkers.

Wittmann J, Jäck HM.

Biochim Biophys Acta. 2010 Dec;1806(2):200-7. doi: 10.1016/j.bbcan.2010.07.002. Epub 2010 Jul 13. Review.

PMID:
20637263
15.

MicroRNA-21 in colorectal cancer: "Just another brick in the wall"?

Stintzing S, Lenz HJ.

J Natl Cancer Inst. 2013 Jun 19;105(12):840-1. doi: 10.1093/jnci/djt128. Epub 2013 May 23. No abstract available.

16.

Serum microRNAs as non-invasive biomarkers for cancer.

Brase JC, Wuttig D, Kuner R, Sültmann H.

Mol Cancer. 2010 Nov 26;9:306. doi: 10.1186/1476-4598-9-306. Review.

17.

miRNAs as biomarkers in colorectal cancer diagnosis and prognosis.

Ju J.

Bioanalysis. 2010 May;2(5):901-6. doi: 10.4155/bio.10.45. Review.

18.

Systemic microRNAs: novel biomarkers for colorectal and other cancers?

Heneghan HM, Miller N, Kerin MJ.

Gut. 2010 Jul;59(7):1002-4; author reply 1004. doi: 10.1136/gut.2009.200121. No abstract available.

PMID:
20581247
19.

MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers.

Nugent M, Miller N, Kerin MJ.

Eur J Surg Oncol. 2011 Aug;37(8):649-54. doi: 10.1016/j.ejso.2011.05.005. Epub 2011 May 31. Review.

PMID:
21632200
20.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

Items per page

Supplemental Content

Write to the Help Desk